Joga Gobburu

UMSOP Announces Recipients of Two Prestigious Scholarships

July 9, 2025

The Gyi and Wagner Scholarships support student pharmacists interested in pharmapreneurship.

Breakthroughs Can’t Wait: Revolutionizing Emergency Medicine

June 5, 2025

Allan Doctor, MD, of the School of Medicine and Joga Gobburu, PhD, MBA, of the School of Pharmacy are optimistic they are on the cusp of developing the world’s first viable artificial blood.

Leader in Pharmacometric Innovation and Drug Development Named Gyi Professor in Pharmapreneurship

May 8, 2025

Nationally and internationally recognized faculty member exemplifies the entrepreneurial spirit that defines pharmapreneurship.

David J. Ramsay Entrepreneur of the Year: Joga Gobburu, PhD, MBA, MSc

September 30, 2024

Joga Gobburu, PhD, MBA, MSc, is a trailblazer in the field of translational medicine, which integrates knowledge across experiments and clinical trials to lay the groundwork for strategic decisions on drug regulation and/or drug development and precision medicine.

Pharmacometrician Receives Lewis B. Sheiner Lecturer Award for Outstanding Lifetime Achievements

November 13, 2023

Joga Gobburu is professor and director of the Center for Translational Medicine.

UMSOP’s Center for Translational Medicine to Aid Artificial Blood Research

February 22, 2023

CTM faculty sought for pharmacometrics expertise.

Gilead Sciences and University of Maryland School of Pharmacy Collaborate to Develop Future Leaders in Pharmacometrics

August 20, 2021

New two-year postdoctoral fellowship will provide hands-on technical training, unique drug development experiences, and supervised research projects.

University of Maryland, Baltimore (UMB) Grants Pumas-AI Exclusive License of Analytics Platform to Enhance Drug Development

August 16, 2021

Company spun out of University of Maryland School of Pharmacy provides a sophisticated pharmaceutical modeling and simulation platform with upgraded Productivity and Compliance Suites.

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

May 7, 2020

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

Pumas-AI Launches Pumas Software to Advance Drug Development, Patient Care

July 19, 2019

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

Gobburu Receives ASCPT’s Sheiner-Beal Pharmacometrics Award

March 15, 2019

International award recognizes outstanding achievements at the forefront of research or leadership in the field of pharmacometrics.

SOP, UCSF Partner for New Initiative on Pediatric Drug and Device Development

September 11, 2017

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.